{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T11:45:48Z","timestamp":1759837548005},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,5,26]],"date-time":"2012-05-26T00:00:00Z","timestamp":1337990400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s12928-012-0105-4","type":"journal-article","created":{"date-parts":[[2012,5,25]],"date-time":"2012-05-25T10:25:18Z","timestamp":1337941518000},"page":"161-167","source":"Crossref","is-referenced-by-count":8,"title":["The long-term efficacy of cilostazol in addition to dual antiplatelet therapy after sirolimus-eluting stent implantation for Japanese patients: an analysis of the 3-year follow-up outcomes from the j-Cypher registry"],"prefix":"10.1007","volume":"27","author":[{"given":"Tetsushi","family":"Nakao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazushige","family":"Kadota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakiyo","family":"Nobuyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Mitsudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,26]]},"reference":[{"key":"105_CR1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","volume":"334","author":"A Schomig","year":"1996","unstructured":"Schomig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med. 1996;334:1084\u20139.","journal-title":"N Engl J Med"},{"key":"105_CR2","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1161\/CIRCULATIONAHA.104.530097","volume":"112","author":"JS Douglas Jr","year":"2005","unstructured":"Douglas JS Jr, Holmes DR Jr, Kereiakes DJ, Grines CL, Block E, Ghazzal ZM, et al. Coronary stent restenosis in patients treated with cilostazol. Circulation. 2005;112:2826\u201332.","journal-title":"Circulation"},{"key":"105_CR3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.amjcard.2009.08.667","volume":"105","author":"SW Lee","year":"2010","unstructured":"Lee SW, Chun KJ, Park SW, Kim HS, Kim YH, Yun SC, et al. Comparison of triple antiplatelet therapy and dual antiplatelet therapy in patients at high risk of restenosis after drug-eluting stent implantation (from the DECLARE-DIABETES and -LONG Trials). Am J Cardiol. 2010;105:168\u201373.","journal-title":"Am J Cardiol"},{"key":"105_CR4","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.jacc.2005.07.048","volume":"46","author":"SW Lee","year":"2005","unstructured":"Lee SW, Park SW, Hong MK, Kim YH, Lee BK, Song JM, et al. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis. J Am Coll Cardiol. 2005;46:1833\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"105_CR5","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jacc.2008.12.025","volume":"53","author":"YH Jeong","year":"2009","unstructured":"Jeong YH, Lee SW, Choi BR, Kim IS, Seo MK, Kwak CH, et al. Randomized comparison of adjunctive cilostazol versus high maintenance dose clopidogrel in patients with high post-treatment platelet reactivity: results of the ACCEL-RESISTANCE (adjunctive cilostazol versus high maintenance dose clopidogrel in patients with clopidogrel resistance) randomized study. J Am Coll Cardiol. 2009;53:1101\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"105_CR6","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1253\/circj.71.1685","volume":"71","author":"PK Min","year":"2007","unstructured":"Min PK, Jung JH, Ko YG, Choi D, Jang Y, Shim WH. Effect of cilostazol on in-stent neointimal hyperplasia after coronary artery stenting: a quantative coronary angiography and volumetric intravascular ultrasound study. Circ J. 2007;71:1685\u201390.","journal-title":"Circ J"},{"key":"105_CR7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ahj.2009.01.006","volume":"157","author":"Y Han","year":"2009","unstructured":"Han Y, Li Y, Wang S, Jing Q, Wang Z, Wang D, et al. Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: a randomized, controlled study. Am Heart J. 2009;157:733\u20139.","journal-title":"Am Heart J"},{"key":"105_CR8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/CIRCULATIONAHA.108.808311","volume":"119","author":"T Kimura","year":"2009","unstructured":"Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation. 2009;119:987\u201395.","journal-title":"Circulation"},{"key":"105_CR9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacc.2004.12.082","volume":"46","author":"PW Serruys","year":"2005","unstructured":"Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the arterial revascularization therapies study (ARTS) randomized trial. J Am Coll Cardiol. 2005;46:575\u201381.","journal-title":"J Am Coll Cardiol"},{"key":"105_CR10","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1056\/NEJMoa067731","volume":"356","author":"L Mauri","year":"2007","unstructured":"Mauri L, Hsieh WH, Massaro JM, Ho KK, D\u2019Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356:1020\u20139.","journal-title":"N Engl J Med"},{"key":"105_CR11","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1253\/circj.71.1867","volume":"71","author":"JY Kim","year":"2007","unstructured":"Kim JY, Lee K, Shin M, Ahn M, Choe H, Yoo BS, et al. Cilostazol could ameliorate platelet responsiveness to clopidogrel in patients undergoing primary percutaneous coronary intervention. Circ J. 2007;71:1867\u201372.","journal-title":"Circ J"},{"key":"105_CR12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijcard.2008.02.016","volume":"134","author":"CY Shim","year":"2009","unstructured":"Shim CY, Yoon SJ, Park S, Kim JS, Choi JR, Ko YG, et al. The clopidogrel resistance can be attenuated with triple antiplatelet therapy in patients undergoing drug-eluting stents implantation. Int J Cardiol. 2009;134:351\u20135.","journal-title":"Int J Cardiol"},{"key":"105_CR13","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ahj.2007.12.024","volume":"155","author":"GG Biondi-Zoccai","year":"2008","unstructured":"Biondi-Zoccai GG, Lotrionte M, Anselmino M, Moretti C, Agostoni P, Testa L, et al. Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention. Am Heart J. 2008;155:1081\u20139.","journal-title":"Am Heart J"},{"key":"105_CR14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/0091270009338940","volume":"50","author":"DL Jennings","year":"2010","unstructured":"Jennings DL, Kalus JS. Addition of cilostazol to aspirin and a thienopyridine for prevention of restenosis after coronary artery stenting: a meta-analysis. J Clin Pharmacol. 2010;50:415\u201321.","journal-title":"J Clin Pharmacol"},{"key":"105_CR15","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jacc.2007.11.049","volume":"51","author":"SW Lee","year":"2008","unstructured":"Lee SW, Park SW, Kim YH, Yun SC, Park DW, Lee CW, et al. Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (a randomized comparison of triple antiplatelet therapy with dual antiplatelet therapy after drug-eluting stent implantation in diabetic patients). J Am Coll Cardiol. 2008;51:1181\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"105_CR16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03402.x","volume":"68","author":"I Singh","year":"2009","unstructured":"Singh I, Shafiq N, Pandhi P, Reddy S, Pattanaik S, Sharma Y, et al. Triple antiplatelet therapy versus dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: an evidence-based approach to answering a clinical query. Br J Clin Pharmacol. 2009;68:4\u201313.","journal-title":"Br J Clin Pharmacol"},{"key":"105_CR17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijcard.2011.05.020","volume":"150","author":"H Takagi","year":"2011","unstructured":"Takagi H, Umemoto T. A meta-analysis of randomized trials of triple versus dual antiplatelet therapy after stent-based percutaneous coronary intervention. Int J Cardiol. 2011;150:228\u201330.","journal-title":"Int J Cardiol"},{"key":"105_CR18","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jacc.2010.10.035","volume":"57","author":"SW Lee","year":"2011","unstructured":"Lee SW, Park SW, Kim YH, Yun SC, Park DW, Lee CW, et al. A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with long coronary lesions) trial. J Am Coll Cardiol. 2011;57:1264\u201370.","journal-title":"J Am Coll Cardiol"},{"key":"105_CR19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jacc.2010.08.631","volume":"57","author":"JW Suh","year":"2011","unstructured":"Suh JW, Lee SP, Park KW, Lee HY, Kang HJ, Koo BK, et al. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial. J Am Coll Cardiol. 2011;57:280\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"105_CR20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jacc.2008.09.020","volume":"53","author":"Y Soga","year":"2009","unstructured":"Soga Y, Yokoi H, Kawasaki T, Nakashima H, Tsurugida M, Hikichi Y, et al. Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication. J Am Coll Cardiol. 2009;53:48\u201353.","journal-title":"J Am Coll Cardiol"},{"key":"105_CR21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jvs.2009.08.040","volume":"51","author":"T Takigawa","year":"2010","unstructured":"Takigawa T, Matsumaru Y, Hayakawa M, Nemoto S, Matsumura A. Cilostazol reduces restenosis after carotid artery stenting. J Vasc Surg. 2010;51:51\u20136.","journal-title":"J Vasc Surg"},{"key":"105_CR22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4070\/kcj.2009.39.5.190","volume":"39","author":"KH Park","year":"2009","unstructured":"Park KH, Jeong MH, Lee MG, Ko JS, Lee SE, Kang WY, et al. Efficacy of triple anti-platelet therapy including cilostazol in acute myocardial infarction patients undergoing drug-eluting stent implantation. Korean Circ J. 2009;39:190\u20137.","journal-title":"Korean Circ J"},{"key":"105_CR23","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1161\/CIRCULATIONAHA.108.822791","volume":"119","author":"KY Chen","year":"2009","unstructured":"Chen KY, Rha SW, Li YJ, Poddar KL, Jin Z, Minami Y, et al. Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Circulation. 2009;119:3207\u201314.","journal-title":"Circulation"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-012-0105-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12928-012-0105-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-012-0105-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T14:25:29Z","timestamp":1559485529000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12928-012-0105-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,26]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["105"],"URL":"https:\/\/doi.org\/10.1007\/s12928-012-0105-4","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,26]]}}}